 
                            
                                    Cancer                                
                                                            ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
                                    Health & Wellness                                
                                                            June 10, 2009
                                Sign up to receive email notifications
Explore more topics
 Sign up
 Sign up
               
                              Mayo Clinic Connect
An online patient support community
